Improved chemical strategies for the targeted therapy of cancer

Angew Chem Int Ed Engl. 2003 Oct 13;42(39):4726-8. doi: 10.1002/anie.200301666.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / pharmacokinetics
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / therapeutic use
  • Bridged-Ring Compounds / administration & dosage
  • Bridged-Ring Compounds / chemistry
  • Doxorubicin / administration & dosage
  • Doxorubicin / chemistry
  • Drug Carriers / pharmacokinetics
  • Drug Delivery Systems*
  • Humans
  • Ligands
  • Mandelic Acids / chemistry
  • Mandelic Acids / pharmacokinetics
  • Neoplasms / drug therapy*
  • Oligopeptides / administration & dosage
  • Oligopeptides / chemistry
  • Paclitaxel / administration & dosage
  • Paclitaxel / chemistry
  • Taxoids / administration & dosage
  • Taxoids / chemistry

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Bridged-Ring Compounds
  • Drug Carriers
  • Ligands
  • Mandelic Acids
  • Oligopeptides
  • Taxoids
  • 4-hydroxymandelic acid
  • Doxorubicin
  • IDN 5109
  • Paclitaxel